<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302843/" ref="ordinalpos=3986&amp;ncbi_uid=3860528&amp;link_uid=PMC3302843" image-link="/pmc/articles/PMC3302843/figure/pone-0033250-g010/" class="imagepopup">Figure 10. Schematic illustration of oxygen→ARSB→C4S→galectin-3→AP-1→HIF-1α <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia. </a></div><br /><div class="p4l_captionBody">Normoxic and hypoxic conditions lead to differences in signaling, attributable to reduced ARSB activity leading to increase in chondroitin-4-sulfation, reduced galectin-3 binding to the more highly sulfated C4S, increased nuclear translocalization of galectin-3, and increased transcriptional events in association with activation of AP-1, including increased expression of HIF-1α. [ARSB = arylsulfatase B; FGE = formylglycine (oxoalanine) generating enzyme; C4S = chondroitin-4-sulfate].</div></div>